LEADER 00969nam0-22003251i-450 
001 990007464370403321
005 20200610113829.0
035   $a000746437
035   $aFED01000746437
035   $a(Aleph)000746437FED01
035   $a000746437
100   $a20030814d1973----km-y0itay50------ba
101 0 $aita
102   $aIT
105   $aa       001yy
200 1 $aGuida alla natura della Sardegna$fdi Fulco Pratesi, Franco Tassi$gcon la collaborazione del World Wildlife Fund
210   $a[Milano]$cMondadori$d1973
215   $a338 p.$cin gran parte ill.$d24 cm
610 0 $aSardegna
610 0 $aItalia$aGuide
702  1$aPratesi,$bFulco$f<1934- >
702  1$aTassi,$bFranco$f<1938- >
712 02$aWWF$9<World wildlife fund>
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990007464370403321
952   $aA-IT 0008$bI.G.9795$fILFGE
959   $aILFGE
996   $aGuida alla natura della Sardegna$9674158
997   $aUNINA

LEADER 02749nam  2200673 a 450 
001 9910141290003321
005 20230628105033.0
010   $a9786613640307
010   $a9781280663376
010   $a1280663375
010   $a9783527651269
010   $a3527651268
010   $a9783527632909
010   $a3527632905
010   $a9783527651252
010   $a352765125X
035   $a(CKB)2670000000169189
035   $a(EBL)875950
035   $a(OCoLC)784885298
035   $a(SSID)ssj0000657939
035   $a(PQKBManifestationID)12248855
035   $a(PQKBTitleCode)TC0000657939
035   $a(PQKBWorkID)10680886
035   $a(PQKB)11101280
035   $a(MiAaPQ)EBC875950
035   $a(Au-PeEL)EBL875950
035   $a(CaPaEBR)ebr10558796
035   $a(CaONFJC)MIL364030
035   $a(Perlego)1011701
035   $a(EXLCZ)992670000000169189
100   $a20120604d2012      uy         0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 00$aPharmaceutical biotechnology $edrug discovery and clinical applications /$fedited by Oliver Kayser and Heribert Warzecha
205   $a2nd., completely rev. and greatly enl. ed.
210   $aWeinheim $cWiley-Blackwell$d2012
215   $a1 online resource (677 p.)
300   $aDescription based upon print version of record.
311 08$a9783527329946 
311 08$a3527329943 
320   $aIncludes bibliographical references and index.
327   $apt. 1. Concepts and methods for recombinant drug production -- pt. 2. Bringing the drug into action : from downstreaming to approval -- pt. 3. Vaccines -- pt. 4. Recent applications in pharmaceutical biotechnology.
330   $aThis second edition of a very successful book is thoroughly updated with existing chapters completely rewritten while the content has more than doubled from 16 to 36 chapters. As with the first edition, the focus is on industrial pharmaceutical research, written by a team of industry experts from around the world, while quality and safety management, drug approval and regulation, patenting issues, and biotechnology fundamentals are also covered. In addition, this new edition now not only includes biotech drug development but also the use of biopharmaceuticals in diagnostics and vaccinations. <
606   $aPharmaceutical biotechnology
615  0$aPharmaceutical biotechnology.
676   $a615.19
676   $a615/.19
701   $aKayser$b Oliver$0891116
701   $aWarzecha$b Heribert$0987913
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910141290003321
996   $aPharmaceutical biotechnology$92258846
997   $aUNINA